3. Summary
Global Market Direct’s pharmaceuticals report, “Winston Pharmaceuticals,
Inc. - Product Pipeline Review - 2012” provides data on the Winston
Pharmaceuticals, Inc.’s research and development focus. The report includes
information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Winston Pharmaceuticals, Inc.’s corporate
website, SEC filings, investor presentations and featured press releases,
both from Winston Pharmaceuticals, Inc. and industry-specific third party
sources, put together by Global Markets Direct’s team.
4. Scope
- Winston Pharmaceuticals, Inc. - Brief Winston Pharmaceuticals, Inc. overview
including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of Winston Pharmaceuticals, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Reasons to buy
- Evaluate Winston Pharmaceuticals, Inc.’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of Winston Pharmaceuticals, Inc. in its therapy areas of
focus.
- Identify new drug targets and therapeutic classes in the Winston Pharmaceuticals,
Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas.
5. Table of Contents :
List of Tables 4
List of Figures 4
Winston Pharmaceuticals, Inc. Snapshot 5
Winston Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Winston Pharmaceuticals, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Winston Pharmaceuticals, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Winston Pharmaceuticals, Inc. – Pipeline Products Glance 10
Winston Pharmaceuticals, Inc. – Late Stage Pipeline 10
Registration Filed Products/Combination Treatment Modalities 10
Phase III Products/Combination Treatment Modalities 11
Winston Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Winston Pharmaceuticals, Inc. – Early Stage Pipeline Products
14……………………
6. Please follow link if you want More Related
Reports :
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product
Pipeline Review – 2012&PubId=&pagenum=1
